Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Gear, apparel, accessories and more to show off your purple pride.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers ...

Together, we can improve pancreatic cancer outcomes. PanCAN supports our patient, caregiver and healthcare professional communities by providing free information and resources. Our services are backed ...

PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.

One of PanCAN’s key strategies to accelerate progress for patients with pancreatic cancer is to increase the federal research funding available to researchers around the country. Since 1999, we and ...

PanCAN and our national grassroots community of advocates led the charge to create the first-ever Pancreatic Cancer Research Program (PCARP) at the Department of Defense (DoD) in 2019. That year, ...

The 119th Congress was sworn in on January 3, including 56 new members across both the House and Senate – all of whom need to be educated about the critical role they play in the urgent fight against ...

Congress sets the spending priorities and funds the federal government each year. That’s why our advocacy efforts are focused on reaching and influencing members of the 119th Congress. PanCAN advocates ...

Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading cause of cancer-related death in the U.S. Their annual report also includes ...